跳至主要内容
临床试验/NCT05222659
NCT05222659已完成不适用

Perioperative Glucose and Insulin Changes in Major Urologic Surgeries

University of Kansas Medical Center1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
To determine the perioperative glycemic changes longitudinally in patients undergoing major urologic surgeries.

研究概览

简要总结

Urological surgery patients will have their blood glucose measured before, during, and after surgery. Blood glucose will be measured using a continuous glucose monitor (CGM) device. We hypothesize the presence of a hyperglycemic state towards the end of surgery due to increased metabolic demand.

详细描述

Surgical stress causes acute insulin resistance, increased circulating free-fatty acids, and reduced blood glucose uptake resulting in hyperglycemia. Intraoperative and postoperative glucose levels are typically only monitored in the diabetic or cardiac surgical patient. There is a lack of data on perioperative glucose levels in most prolonged surgeries and thus a barrier in determining the best glycemic management strategy to prevent or resolve acute insulin resistance and hyperglycemia. Obtaining blood glucose by CGM is less invasive and will avert disruption of current surgical pathways and standards of care while also producing reliable glucose measurements.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult (≥18 years) undergoing a major urologic surgery (proposed case duration >4 hours) at The University of Kansas Medical Center (KUMC)
  • English speaking

排除标准

  • Diagnosis of Type 1 or Type 2 diabetes mellitus or an A1C > 6.5%
  • Pregnant or lactating
  • Known allergy to milk, soy, egg, wheat, peanuts, or tree nuts
  • Swallowing difficulties

结局指标

主要结局

To determine the perioperative glycemic changes longitudinally in patients undergoing major urologic surgeries.

时间窗: Perioperatively up to post-operative day 4

Interstitial blood glucose levels measured by Continuous Glucose Monitor (CGM) device, in mg/dL

次要结局

  • To determine the effect of perioperative insulin levels on glycemic variations in patients undergoing major urologic surgeries.(Perioperatively up to post-operative day 4)
  • To determine the effect of perioperative insulin, C-peptide, and Free-Fatty Acid (FFA)(Perioperatively up to post-operative day 4)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jill Hamilton-Reeves, PhD RD LD

Associate Professor

University of Kansas Medical Center

研究点 (1)

Loading locations...

相似试验

Perioperative Glucose and Insulin Changes in Major... | 临床试验